Etude de cas : Syndrome de Morvan et Myasthénie Gravis liés à des mutations familiales du gène de la fièvre méditerra...

Rubrique ouverte à tous en lecture seule.
POUR ACCEDER AUX NOMBREUX AUTRES FORUMS IL EST NECESSAIRE DE S'INSCRIRE (fonction M'enregistrer en haut à droite de l'écran).
Répondre
Avatar du membre

Auteur du sujet
Pboulanger
Administrateur
Administrateur
Messages : 4717
Enregistré le : 02 févr. 2010 18:41
Localisation : La Chapelle en Serval F-60520
    Windows 8.1 Firefox
Genre :
Zodiaque : Lion
Âge : 61
Contact :
France

Etude de cas : Syndrome de Morvan et Myasthénie Gravis liés à des mutations familiales du gène de la fièvre méditerra...

Message par Pboulanger » 05 avr. 2016 01:08

:hi:

Lu sur http://www.ncbi.nlm.nih.gov/pubmed/27026266
Traduction disponible directement en cliquant en bas à droite de ce message sur notre forum
Image
J Neuroinflammation. 2016 Mar 29;13(1):68. doi: 10.1186/s12974-016-0533-7.
Morvan's syndrome and myasthenia gravis related to familial Mediterranean fever gene mutations.
Koge J1, Hayashi S1, Murai H2, Yokoyama J1, Mizuno Y1, Uehara T1, Ueda N3, Watanabe O4, Takashima H4, Kira J5.
Author information

Abstract
  • BACKGROUND:
    We present the first case of Morvan's syndrome (MoS) and myasthenia gravis (MG) related to familial Mediterranean fever (FMF) gene mutations.
  • CASE PRESENTATION:
    A 40-year-old woman with a 1-year history of bilateral ptosis and limb muscle weakness presented to our hospital. She also had memory impairment, insomnia, hyperhidrosis, and muscle twitches.
    Electromyography confirmed widespread myokymia, and there was evidence of temporal region dysfunction on electroencephalography.
    Anti-voltage-gated potassium channel complex antibodies and anti-acetylcholine receptor antibodies were both positive. Edrophonium administration was effective for bilateral ptosis and muscle weakness.
    She and her family experienced self-limiting febrile attacks with arthralgia, which led us to suspect FMF.
    Genetic analyses revealed compound heterozygous mutations in exon 2 of the MEFV gene (L110P/E148Q).
    From these findings, a diagnosis of MoS and MG complicated with MEFV gene mutations was made.

    Intravenous high-dose corticosteroids, plasma exchange, and intravenous immunoglobulin resulted in only transient, limited improvement, and frequent relapses, especially in the myasthenic symptoms. Interleukin (IL)-6, IL-1β, and tumor necrosis factor-α were markedly elevated in the serum, which was considered to be derived from the MEFV mutations and responsible for the resistance to immunotherapy.
  • CONCLUSION:
    The present case illustrates a possible link between auto-inflammation and auto-antibody-mediated neurological diseases.
Amicalement,
Image

Répondre

Retourner vers « Informations »